Cardiometabolic Health

Business

Cuban's Healthcare Poll Exposes 'Pick-Your-Pain' Dilemma: Deductibles Edge Out Premiums in Voter Frustration

A social media poll by billionaire Mark Cuban reveals a near-even split on which part of U.S. health insurance is more financially painful—premiums or deductibles. The results, and the outpouring of personal stories in the replies, underscore a system many describe as forcing impossible choices amid relentlessly rising costs.

Jan 30, 2026

Business

Trump's Medicare Advantage Payment Freeze Sends Healthcare Stocks Reeling, Threatens Insurer Profits

A proposed near-zero payment increase for Medicare Advantage plans by the Trump administration has blindsided Wall Street, erasing billions in market value and raising fears of a prolonged downturn for major health insurers.

Jan 30, 2026

Business

Medical Properties Trust Shifts HQ to Alabama, Signaling Strategic Focus on Core U.S. Healthcare Portfolio

Medical Properties Trust (NYSE: MPW), a major healthcare real estate investment trust, is relocating its corporate headquarters to Birmingham, Alabama. The move is seen as a strategic effort to streamline operations and deepen ties with its primary U.S. hospital network, lenders, and investors, amid an evolving landscape for hospital ownership and healthcare infrastructure.

Jan 30, 2026

World

Federal Judge Dismisses Key Charges in UnitedHealth CEO Murder Case

A New York federal judge has dismissed murder and weapons charges against Luigi Mangione, the man accused of killing UnitedHealthcare's CEO. The ruling deals a significant setback to federal prosecutors and removes the possibility of a death penalty in the high-profile case.

Jan 30, 2026

World

Israeli Military Briefing Reportedly Confirms Gaza Death Toll Nears 70,000, Aligning with Palestinian Health Ministry Figures

In a significant shift, Israeli military officials have privately told journalists that approximately 70,000 Palestinians have been killed in the Gaza war, a figure that largely corroborates the enclave's health ministry data, according to local media reports.

Jan 30, 2026

Business

Oscar Health Faces Headwinds as CMS Proposes Tighter Medicare Advantage Rules

The Centers for Medicare & Medicaid Services (CMS) has unveiled a proposed payment update for Medicare Advantage plans that falls below industry expectations, coupled with stricter risk-adjustment regulations. This dual challenge pressures insurers like Oscar Health (NYSE: OSCR), whose tech-driven model is now under the microscope as profitability margins face a squeeze.

Jan 30, 2026

Business

Fractyl Health Charts Path for Revita as Potential Solution to Post-GLP-1 Weight Regain

Fractyl Health's Revita procedure shows promise in maintaining weight after stopping GLP-1 drugs, with new six-month data prompting the company to seek a streamlined FDA pathway. A packed 2026 roadmap aims for a U.S. submission, but financial pressures loom.

Jan 30, 2026

Business

SAP Shifts Healthcare Strategy, Appoints New North America Chief Amid Market Scrutiny

SAP discontinues its legacy IS-H healthcare software in the DACH region, impacting dozens of hospitals, while appointing David Robinson to lead its crucial North American operations. The moves signal a strategic pivot as the enterprise software giant navigates a complex market landscape.

Jan 30, 2026

Business

P&G Bolsters Health Portfolio with Acquisition of Digestive Wellness Brand Wonderbelly

Consumer goods giant Procter & Gamble has agreed to acquire Wonderbelly, a fast-growing brand in the 'free-from' digestive health space, signaling a deeper push into the lucrative wellness category and a bid to attract younger, label-conscious consumers.

Jan 30, 2026

Business

Medicare Advantage Funding Freeze Puts Clover Health's Profitability in the Spotlight

Proposed flat payment rates for 2027 by CMS intensify margin pressures on Medicare Advantage insurers like Clover Health, raising investor concerns about cost management and growth prospects in a tightening regulatory landscape.

Jan 30, 2026

Business

Cardinal Health Shares Surge on Strong Earnings, But Valuation Questions Loom

Cardinal Health (CAH) stock has drawn renewed investor interest following robust financial results, with revenue topping $234 billion and net income near $1.6 billion. The healthcare distributor's shares have rallied over 66% in the past year, though its premium valuation compared to peers is sparking debate among analysts.

Jan 30, 2026

Business

UPS Pivots with Sweeping Restructuring: 30,000 Jobs Cut, Focus Shifts to Healthcare and High-Margin Clients

Facing uneven long-term performance, UPS announces a major strategic overhaul involving significant job reductions, facility closures, and a deliberate move away from low-margin Amazon volume. The company is betting big on healthcare logistics through acquisitions to bolster its global cold chain network.

Jan 30, 2026

Business

Siemens Healthineers Bets on Irish Innovation with New €10 Million R&D Hub

The medtech giant inaugurates a Centre of Excellence in Swords, aiming to accelerate development of its Atellica diagnostic systems and bolster Ireland's life sciences sector amid strategic corporate shifts.

Feb 2, 2026

Business

Fevara's Financial Health Raises Red Flags: Is the Recent Stock Rally Built on Shaky Ground?

Despite a 5% share price gain over the last quarter, a deep dive into Fevara plc's (LON:FVA) fundamentals reveals concerning trends. With a declining net income and a high dividend payout strategy stifling reinvestment, analysts question the sustainability of its current valuation.

Feb 2, 2026

Business

Market Movers: Defense, Tech, and Healthcare Stocks See Volatile Week

A week of significant stock swings saw Lockheed Martin and Texas Instruments surge on strong outlooks, while Humana plunged on regulatory headwinds. Here’s what drove the action and what analysts are saying.

Jan 30, 2026

Business

ResMed Posts Strong Q4 on Mask Innovation and Digital Health Surge, Beats Estimates

Medical device maker ResMed (RMD) reported fourth-quarter revenue of $1.42 billion, an 11% year-over-year increase that surpassed Wall Street forecasts. Non-GAAP earnings per share reached $2.81, also topping analyst expectations.

Jan 30, 2026

Business

Guggenheim Backs AtaiBeckley with Buy Rating, $11 Target, Citing Breakthrough Potential in Mental Health

Guggenheim Securities has initiated coverage of clinical-stage biopharma AtaiBeckley with a Buy rating and an $11 price target, highlighting its leadership in next-generation psychiatric treatments following its merger with Beckley Psytech.

Jan 30, 2026

Business

Baxter International's Rocky Road: Can the Healthcare Giant Regain Wall Street's Confidence?

After a punishing year of underperformance and operational setbacks, Baxter International faces a skeptical analyst community. While some see deep value, the consensus remains firmly on hold as the company navigates product challenges and revised guidance.

Jan 30, 2026

Business

OGE Energy's Financial Health: A Closer Look at Returns and Rising Debt

OGE Energy Corp. posts a return on equity in line with industry peers, but a deeper dive reveals a reliance on debt that could signal heightened risk for investors in the evolving utilities sector.

Jan 30, 2026

Business

Pennant Group Stock Surges 15%: Is the Healthcare Provider Still a Bargain?

Shares of The Pennant Group (PNTG) have climbed 15% in recent months, yet remain below yearly highs. With a P/E ratio significantly above the industry average, analysts are divided on whether the stock's growth prospects justify its premium valuation.

Jan 30, 2026